Infectious Disease

Current transmission rates from primary cases to secondary cases could cause Ebola epidemic to explode.

Organization warns disease is spreading faster than it can be contained.

Lauren Forni, PharmD, RPH, of CVS/pharmacy, explains why pharmacists are providing vaccines to 2014 National Association of Chain Drug Stores (NACDS) Total Store Expo attendees.

Countries at highest risk for Ebola transmission identified through animal migration patterns.

Commentary stresses importance of safe removal of protective gear among those caring for infected patients.

A single dose of intramuscular peramivir (Rapivab) alleviated the symptoms of influenza in 2 clinical trials.

The FDA has approved the use of Sanofi's Menactra vaccine as a booster immunization against meningococcal disease in patients at continued risk.

Ebola epidemic expected to surge, though relief workers are already overwhelmed by increasing patient volume.

Progress made on new Ebola drugs as US government pledges resources to West Africa.

Researchers seek to get ahead of potential future Ebola outbreaks.

TIM-family proteins may be able to block a wide range of viral infections.

Experimental drug results in 100% recovery in primates up to 5 days following infection.

Vast majority of parents are opting for their young children to receive potentially lifesaving vaccines despite the controversy surrounding their right to refuse such immunizations.

Treatment co-developed by National Institutes of Health and GlaxoSmithKline gets fast-tracked as World Health Organization issues dire prediction.

Limitations in available staff and protective equipment put medical personnel at increased risk.

Efficacy of treatment still undetermined as World Health Organization raises cost of battle strategy.

A different Ebola strain reported in the Congo as researchers race to find a vaccine.

Study suggests pharmacists are more than qualified to navigate outpatients with HIV through treatment options.

Ceasing treatment may be the only way to determine whether HIV is cured, but doing so carries long-term risks.

Doctors say experimental Ebola drugs should not be limited to well-off patients.

Promising treatment protects nonhuman primates from Marburg virus up to 3 days after infection.

The FDA has approved the first needle-free device for injecting the Afluria influenza vaccine in adult patients aged 18 to 64 years.

Doctors Without Borders says virus cannot be contained without massive mobilization of resources to West Africa.

Ebola-related death toll climbs above 1200 as health care workers face increased threats from desperate region.